Gennex Laboratories (BOM:531739) Total Equity: ₹2,328 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531739 Gennex Laboratories Ltd BOM:531739
80 GF Score
Price ₹9.08
GF Value ₹15.53
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Gennex Laboratories Total Equity?

Gennex Laboratories BOM:531739 +0.11% 80 Total Equity is ₹2,328 Mil as of Mar. 2026. GuruFocus rates BOM:531739 with a GF Score™ of 80/100 and a GF Value™ of ₹15.53 (Possible Value Trap). The stock has 7 warning signs investors should review.

Gennex Laboratories's total equity for the quarter that ended in Mar. 2026 was ₹2,328 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Gennex Laboratories Total Equity Historical Data

* Premium members only.

The historical data trend for Gennex Laboratories's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gennex Laboratories Total Equity Chart

Gennex Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 438.15 865.15 1,764.65 1,945.87 2,328.36

Gennex Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,945.87 0.00 2,222.58 0.00 2,328.36
BOM:531739
80GF Score
Gennex Laboratories Ltd BOM:531739
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gennex Laboratories Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Gennex Laboratories's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=3486.752-1158.392
=2,328

Gennex Laboratories's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=3486.752-1158.392
=2,328

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₹2,328 Mil mean?
Gennex Laboratories (BOM:531739) has a Total Equity of ₹2,328 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Gennex Laboratories and its competitors.
Is Gennex Laboratories' Total Equity too high?
Gennex Laboratories' current Total Equity is ₹2,328 Mil. Overall, Gennex Laboratories has a GF Score™ of 80/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gennex Laboratories' Total Equity compare to ZTS and UTHR?
Gennex Laboratories' Total Equity of ₹2,328 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Gennex Laboratories and its competitors. Gennex Laboratories's current Total Equity is ₹2,328 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gennex Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Gennex Laboratories (BOM:531739) is currently considered Possible Value Trap. The stock's GF Value™ is ₹15.53, compared to a current price of ₹9.08 — trading 41.5% below its estimated fair value. The current Total Equity is ₹2,328 Mil. Gennex Laboratories' overall GF Score™ is 80/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Gennex Laboratories (BOM:531739), the current Total Equity is ₹2,328 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gennex Laboratories (BOM:531739) Overvalued in 2026?

Based on GuruFocus' analysis, Gennex Laboratories stock appears to be undervalued. The current stock price of ₹9.08 is trading 41.5% below its estimated GF Value™ of ₹15.53. GuruFocus considers Gennex Laboratories to be Possible Value Trap.

Key valuation signals for BOM:531739:

  • Total Equity: ₹2,328 Mil
  • GF Value™: ₹15.53 vs. price of ₹9.08 (41.5% below fair value)
  • GF Score™: 80/100 with 7 warning signs

No single metric tells the full story. See the BOM:531739 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gennex Laboratories Business Description

Address Akash Ganga, Plot No. 144, 4th Floor, Srinagar Colony, Hyderabad, TG, IND, 500 073
Gennex Laboratories Ltd is engaged in the manufacturing of bulk drugs, and intermediates, Biotech Products. Geographically, the group has a business presence in Bangladesh, Egypt, Germany, Guatemala, Iran, Israel and other countries. Its products include Guaifenesin, Methocarbamol, Fluconazole and Phenazopyridine, among others.
80GF Score

Get the complete analysis for BOM:531739

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹9.08
Price
₹15.53
GF Value